{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:57:11Z","timestamp":1792025831990,"version":"4.4.0"},"reference-count":40,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2022,7,20]],"date-time":"2022-07-20T00:00:00Z","timestamp":1658275200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Children"],"abstract":"<jats:p>Lipodystrophy is the most common dermatological complication in patients with diabetes on insulin therapy. Despite the high frequency of lipodystrophy, there are still several difficulties in giving advice about avoidance into practice among children and adolescents with type 1 diabetes and their caregivers. This cross-sectional study aims to evaluate the prevalence of insulin-induced lipodystrophy in a cohort of pediatric patients with type 1 diabetes, to identify associated clinical factors and to assess its influence on glycemic control. Two hundred and twelve patients attending our Diabetes Center during a three-month period were enrolled. The presence of lipodystrophy was assessed by inspection and palpation procedures. Demographic and clinical data including type of treatment, frequency of rotation of insulin administration sites, and glucose metrics of the previous 30 days were assessed and statistically analyzed. Prevalence of lipohypertrophy was 44.3%. Two patients were affected by lipoatrophy (0.9%). Improper rotation of insulin administration sites and low awareness on lipodystrophy were associated to the occurrence of this skin condition (p = 0.050 and p = 0.005, respectively). When comparing patients with and without lipodystrophy, a significant difference in glycemic variability parameters was detected (p = 0.036 for coefficient of variation, p = 0.029 for standard deviation score of glucose levels). Lipodystrophy still represents a common complication in patients on insulin therapy. The present study reveals its negative impact on glycemic variability. This finding emphasizes the importance of prevention strategies to minimize the occurrence of this dermatological complication that may interfere with clinical history of the disease.<\/jats:p>","DOI":"10.3390\/children9071087","type":"journal-article","created":{"date-parts":[[2022,7,21]],"date-time":"2022-07-21T03:34:40Z","timestamp":1658374480000},"page":"1087","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["The Impact of Insulin-Induced Lipodystrophy on Glycemic Variability in Pediatric Patients with Type 1 Diabetes"],"prefix":"10.3390","volume":"9","author":[{"given":"Fortunato","family":"Lombardo","sequence":"first","affiliation":[{"name":"Department of Human Pathology in Adult and Developmental Age \u201cGaetano Barresi\u201d, University of Messina, Via Consolare Valeria 1, 98124 Messina, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8664-1025","authenticated-orcid":false,"given":"Bruno","family":"Bombaci","sequence":"additional","affiliation":[{"name":"Department of Human Pathology in Adult and Developmental Age \u201cGaetano Barresi\u201d, University of Messina, Via Consolare Valeria 1, 98124 Messina, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6695-151X","authenticated-orcid":false,"given":"Angela","family":"Alibrandi","sequence":"additional","affiliation":[{"name":"Unit of Statistical and Mathematical Sciences, Department of Economics, University of Messina, 98122 Messina, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Visalli","sequence":"additional","affiliation":[{"name":"Department of Human Pathology in Adult and Developmental Age \u201cGaetano Barresi\u201d, University of Messina, Via Consolare Valeria 1, 98124 Messina, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppina","family":"Salzano","sequence":"additional","affiliation":[{"name":"Department of Human Pathology in Adult and Developmental Age \u201cGaetano Barresi\u201d, University of Messina, Via Consolare Valeria 1, 98124 Messina, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4369-7798","authenticated-orcid":false,"given":"Stefano","family":"Passanisi","sequence":"additional","affiliation":[{"name":"Department of Human Pathology in Adult and Developmental Age \u201cGaetano Barresi\u201d, University of Messina, Via Consolare Valeria 1, 98124 Messina, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,7,20]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"American Diabetes Association (2021). 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2021. Diabetes Care, 44, S15\u2013S33.","DOI":"10.2337\/dc21-S002"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJM199309303291401","article-title":"The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus","volume":"329","author":"Nathan","year":"1993","journal-title":"N. Engl. J. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.2337\/dci15-0023","article-title":"Insulin\u2019s Role in Diabetes Management: After 90 Years, Still Considered the Essential Black Dress","volume":"38","author":"Cefalu","year":"2015","journal-title":"Diabetes Care"},{"key":"ref_4","first-page":"474","article-title":"Efficacy of advanced hybrid closed loop systems for the management of type 1 diabetes in children","volume":"73","author":"Ferrito","year":"2021","journal-title":"Minerva Pediatr."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Lombardo, F., Salzano, G., Crisafulli, G., Panasiti, I., Alibrandi, A., Messina, M.F., Pajno, G.B., Caminiti, L., and Passanisi, S. (2020). Allergic contact dermatitis in pediatric patients with type 1 diabetes: An emerging issue. Diabetes Res. Clin. Pract., 162.","DOI":"10.1016\/j.diabres.2020.108089"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1055\/s-0029-1211431","article-title":"Prevalence of lipohypertrophy in insulin-treated diabetic patients and predisposing factors","volume":"104","author":"Hauner","year":"1996","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.therap.2021.04.002","article-title":"A meta-analysis and meta-regression on the prevalence of lipohypertrophy in diabetic patients on insulin therapy","volume":"76","author":"Wang","year":"2021","journal-title":"Therapies"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1177\/193229681000400332","article-title":"Insulin absorption from lipodystrophic areas: A (neglected) source of trouble for insulin therapy?","volume":"4","author":"Heinemann","year":"2010","journal-title":"J. Diabetes Sci. Technol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1507\/endocrj.52.623","article-title":"Insulin-induced lipohypertrophy: Report of a case with histopathology","volume":"52","author":"Fujikura","year":"2005","journal-title":"Endocr. J."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1210\/endo-46-1-55","article-title":"Action of insulin on deposition of glycogen and storage of fat in adipose tissue","volume":"46","author":"Renold","year":"1950","journal-title":"Endocrinology"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1136\/adc.2010.183731","article-title":"Lipoatrophy with insulin analogues in type I diabetes","volume":"96","author":"Babiker","year":"2011","journal-title":"Arch. Dis. Child."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1055\/s-2001-18991","article-title":"Insulin antibodies are associated with lipoatrophy but also with lipohypertrophy in children and adolescents with type 1 diabetes","volume":"109","author":"Raile","year":"2001","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1159\/000351708","article-title":"Lipoatrophy is associated with an increased risk of Hashimoto\u2019s thyroiditis and coeliac disease in female patients with type 1 diabetes","volume":"79","author":"Salgin","year":"2013","journal-title":"Horm. Res. Paediatr."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"442","DOI":"10.2337\/dc07-1739","article-title":"Human insulin analog\u2014Induced lipoatrophy","volume":"31","author":"Lopez","year":"2008","journal-title":"Diabetes Care"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"479","DOI":"10.2337\/diacare.7.5.479","article-title":"Diabetic lipohypertrophy delays insulin absorption","volume":"7","author":"Young","year":"1984","journal-title":"Diabetes Care"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.2337\/dc16-0610","article-title":"Insulin Injection into Lipohypertrophic Tissue: Blunted and More Variable Insulin Absorption and Action and Impaired Postprandial Glucose Control","volume":"39","author":"Famulla","year":"2016","journal-title":"Diabetes Care"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Kordonouri, O., Lauterborn, R., and Deiss, D. (2002). Lipohypertrophy in young patients with type 1 diabetes. Diabetes Care, 25.","DOI":"10.2337\/diacare.25.3.634"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1136\/bmj.327.7411.383","article-title":"Poor glycaemic control caused by insulin induced lipohypertrophy","volume":"327","author":"Chowdhury","year":"2003","journal-title":"BMJ"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.2337\/dc08-1987","article-title":"New definition for the partial remission period in children and adolescents with type 1 diabetes","volume":"32","author":"Mortensen","year":"2009","journal-title":"Diabetes Care"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Gentile, S., Guarino, G., Giancaterini, A., Guida, P., Strollo, F., and AMD-OSDI Italian Injection Technique Study Group (2016). A suitable palpation technique allows to identify skin lipohypertrophic lesions in insulin-treated people with diabetes. SpringerPlus, 5.","DOI":"10.1186\/s40064-016-1978-y"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s13300-018-0561-7","article-title":"Impact of Insulin Injection and Infusion Routines on Lipohypertrophy and Glycemic Control in Children and Adults with Diabetes","volume":"10","author":"Deeb","year":"2019","journal-title":"Diabetes Ther."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Omar, M.A., El-Kafoury, A.A., and El-Araby, R.I. (2011). Lipohypertrophy in children and adolescents with type 1 diabetes and the associated factors. BMC Res. Notes, 4.","DOI":"10.1186\/1756-0500-4-290"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Tsadik, A.G., Atey, T.M., Nedi, T., Fantahun, B., and Feyissa, M. (2018). Effect of Insulin-Induced Lipodystrophy on Glycemic Control among Children and Adolescents with Diabetes in Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia. J. Diabetes Res., 2018.","DOI":"10.1155\/2018\/4910962"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1111\/jdi.12742","article-title":"Prevalence of lipohypertrophy in insulin-treated diabetes patients: A systematic review and meta-analysis","volume":"9","author":"Deng","year":"2018","journal-title":"J. Diabetes Investig."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1016\/j.mayocp.2016.06.012","article-title":"Worldwide Injection Technique Questionnaire Study: Injecting Complications and the Role of the Professional","volume":"91","author":"Frid","year":"2016","journal-title":"Mayo Clin. Proc."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.jpeds.2007.10.006","article-title":"Dermatological complications of continuous subcutaneous insulin infusion in children and adolescents","volume":"152","author":"Conwell","year":"2008","journal-title":"J. Pediatr."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Passanisi, S., Salzano, G., and Lombardo, F. (2022). Skin involvement in paediatric patients with type 1 diabetes. Curr. Diabetes Rev., 18.","DOI":"10.2174\/1573399817666210903153837"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"661","DOI":"10.2165\/00128071-200304100-00001","article-title":"Skin-related complications of insulin therapy: Epidemiology and emerging management strategies","volume":"4","author":"Richardson","year":"2003","journal-title":"Am. J. Clin. Dermatol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2165\/00128071-200708010-00003","article-title":"Lipodystrophy reactions to insulin: Effects of continuous insulin infusion and new insulin analogs","volume":"8","author":"Radermecker","year":"2007","journal-title":"Am. J. Clin. Dermatol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1177\/1932296814558348","article-title":"Lipoatrophy in children with type 1 diabetes: An increasing incidence?","volume":"9","author":"Kordonouri","year":"2015","journal-title":"J. Diabetes Sci. Technol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/pedi.12058","article-title":"Insulin injection lipoatrophy recidivus","volume":"15","author":"Rosenbloom","year":"2014","journal-title":"Pediatr. Diabetes"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s00592-017-1066-y","article-title":"Errors in insulin treatment management and risk of lipohypertrophy","volume":"55","author":"Pozzuoli","year":"2018","journal-title":"Acta Diabetol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.diabet.2013.05.006","article-title":"Prevalence and risk factors of lipohypertrophy in insulin-injecting patients with diabetes","volume":"39","author":"Blanco","year":"2013","journal-title":"Diabetes Metab."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/pedi.12718","article-title":"ISPAD Clinical Practice Consensus Guidelines 2018: Insulin treatment in children and adolescents with diabetes","volume":"19","author":"Danne","year":"2018","journal-title":"Pediatr. Diabetes"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s13300-016-0161-3","article-title":"Frequency of Lipohypertrophy and Associated Risk Factors in Young Patients with Type 1 Diabetes: A Cross-Sectional Study","volume":"7","author":"Robert","year":"2016","journal-title":"Diabetes Ther."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Demir, G., Er, E., Atik Akt\u0131nok, Y., \u00d6zen, S., Darcan, \u015e., and G\u00f6k\u015fen, D. (2021). Local complications of insulin administration sites and effect on diabetes management. J. Clin. Nurs., in press.","DOI":"10.1111\/jocn.16071"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.2337\/diacare.28.8.2025","article-title":"Impaired absorption of insulin aspart from lipohypertrophic injection sites","volume":"28","author":"Johansson","year":"2005","journal-title":"Diabetes Care"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/j.1753-0407.2010.00077.x","article-title":"Results and analysis of the 2008\u20132009 Insulin Injection Technique Questionnaire survey","volume":"2","author":"Frid","year":"2010","journal-title":"J. Diabetes"},{"key":"ref_39","first-page":"503","article-title":"Long-term complications of type 1 diabetes: What do we know and what do we need to understand?","volume":"73","author":"Piona","year":"2021","journal-title":"Minerva Pediatr."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1089\/dia.2013.0205","article-title":"Glycemic variability is higher in type 1 diabetes patients with microvascular complications irrespective of glycemic control","volume":"16","author":"Fajmon","year":"2014","journal-title":"Diabetes Technol. Ther."}],"container-title":["Children"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9067\/9\/7\/1087\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T23:55:03Z","timestamp":1760140503000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9067\/9\/7\/1087"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,20]]},"references-count":40,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2022,7]]}},"alternative-id":["children9071087"],"URL":"https:\/\/doi.org\/10.3390\/children9071087","relation":{},"ISSN":["2227-9067"],"issn-type":[{"value":"2227-9067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,20]]}}}